← All trials
NCT05723510
Phase 1Interventional
Includes initial studies to determine the metabolism and pharmacologic actions of drugs in humans, the side effects associated with increasing doses, and to gain early evidence of effectiveness; may include healthy participants and/or patients.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Mar 6, 2023
- Primary completion
- Jul 17, 2023
- Completion date
- Jul 24, 2023
- First posted
- Feb 10, 2023
- Last posted
- Dec 11, 2023
- Enrollment
- 87
- Arms / groups
- 6 / —
- Source
- AACT · ctgov ingestion
Sponsors
- Inno.NLead sponsor
- Jeonbuk National UniversityOfficial
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.